OneMedNet Corp
ONMDWNasdaq
$0.03
↓ -8.6%Jul 16 close · end-of-day
Price
1Y↓ -11.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.9M
Enterprise Value
$1.8M
P/E
—
P/S
1.4
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
-381.8%
Dividend Yield
—
Revenue (TTM)
$1.3M
Net Income (TTM)
-$3.4M
Free Cash Flow (TTM)
-$7.2M
Gross Margin
-50.0%
Operating Margin
-758.4%
Net Margin
-254.3%
ROE
82.2%
ROIC
—
Debt / Equity
-0.0
Net Cash
$57,000.00
Return 1Y
-2.9%
Company profile
Management & directors
- Green AaronChief Executive Officer
- Yu JeffreyChief Medical Officer
Roles derived from SEC Form 4 filings.
Earnings
ONMDW Q 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$96,000.00↓ -29.9%
Diluted EPS-$0.04↓ -33.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $1.2M | $1.0M | $643,000.00 | $1.4M |
| Gross profit | -$360,000.00 | -$129,000.00 | -$281,000.00 | -$503,000.00 |
| Operating income | -$7.7M | -$6.9M | -$9.6M | -$9.7M |
| Net income | -$30.5M | -$33.8M | -$10.1M | -$2.8M |
| Diluted EPS | -$7.66 | -$4.65 | -$0.36 | -$0.06 |
| Operating cash flow | -$4.7M | -$4.8M | -$7.0M | -$7.5M |
| Free cash flow | -$4.8M | -$4.8M | -$7.0M | -$7.5M |
| Gross margin | -31.2% | -12.6% | -43.7% | -37.0% |
| Operating margin | -669.1% | -671.2% | -1493.8% | -711.3% |
| Net margin | -2641.0% | -3308.5% | -1575.3% | -206.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $227,000.00 | $142,000.00 | $26,000.00 | $137,000.00 | $155,000.00 | $177,000.00 | $890,000.00 | $96,000.00 |
| Gross profit | -$102,000.00 | -$84,000.00 | -$26,000.00 | -$224,000.00 | -$241,000.00 | -$222,000.00 | $184,000.00 | -$380,000.00 |
| Operating income | -$2.5M | -$2.3M | -$2.7M | -$2.2M | -$2.1M | -$2.2M | -$3.1M | -$2.6M |
| Net income | -$3.6M | -$2.1M | -$2.4M | -$1.9M | $3.0M | -$741,000.00 | -$3.1M | -$2.5M |
| Diluted EPS | -$0.14 | -$0.07 | -$0.07 | -$0.06 | $0.07 | -$0.01 | -$0.06 | -$0.04 |
| Operating cash flow | -$1.5M | -$1.9M | -$2.0M | -$1.9M | -$2.4M | -$1.6M | -$1.7M | -$1.5M |
| Free cash flow | -$1.5M | -$1.9M | -$2.0M | -$1.9M | -$2.4M | -$1.6M | -$1.7M | -$1.5M |
| Gross margin | -44.9% | -59.2% | -100.0% | -163.5% | -155.5% | -125.4% | 20.7% | -395.8% |
| Operating margin | -1081.1% | -1645.1% | -10438.5% | -1623.4% | -1331.0% | -1262.7% | -353.4% | -2658.3% |
| Net margin | -1581.1% | -1449.3% | -9126.9% | -1388.3% | 1923.9% | -418.6% | -352.8% | -2555.2% |
Company news
Coming soonHeadlines for ONMDW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-23 | Yu Jeffrey· Chief Medical Officer | Buy | 158,730 | $0.63 | $99,999.90 | filing |
| 2026-06-23 | Green Aaron· Chief Executive Officer | Buy | 36,650 | $0.57 | $21,011.45 | filing |
| 2026-06-16 | Yu Jeffrey· Chief Medical Officer | Buy | 172,414 | $0.58 | $100,000.12 | filing |
| 2026-06-15 | Green Aaron· Chief Executive Officer | Buy | 18,702 | $0.54 | $10,091.60 | filing |
| 2026-06-12 | Kosasa Thomas | Buy | 158,730 | $0.63 | $99,999.90 | filing |
| 2026-06-12 | Green Aaron· Chief Executive Officer | Buy | 36,920 | $0.56 | $20,605.05 | filing |
| 2026-05-18 | Kosasa Thomas | Buy | 268,817 | $0.93 | $249,999.81 | filing |
| 2026-04-23 | Kosasa Thomas | Buy | 280,898 | $0.89 | $249,999.22 | filing |
| 2026-04-01 | Yu Jeffrey· Chief Medical Officer | Buy | 903,614 | $0.83 | $749,999.62 | filing |
| 2026-04-01 | Yu Jeffrey· Chief Medical Officer | Award | 219,429 | $0.83 | $182,126.07 | filing |
| 2026-02-06 | Kosasa Thomas | Buy | 595,238 | $0.84 | $499,999.92 | filing |
| 2025-11-26 | Yu Jeffrey· Chief Medical Officer | Award | 45,000 | $0.00 | $0.00 | filing |
| 2025-11-26 | Alleyne Kenneth | Award | 38,219 | $0.00 | $0.00 | filing |
| 2025-11-24 | Yu Jeffrey· Chief Medical Officer | Award | 200,000 | $0.00 | $0.00 | filing |
| 2025-11-18 | Green Aaron· Chief Executive Officer | Sale | 61,555 | $1.20 | $73,902.93 | filing |
| 2025-10-22 | Green Aaron· Chief Executive Officer | Sale | 64,767 | $2.23 | $144,721.86 | filing |
| 2025-09-25 | Yu Jeffrey· Chief Medical Officer | Buy | 1,250 | $1.03 | $1,287.50 | filing |
| 2025-09-24 | Yu Jeffrey· Chief Medical Officer | Buy | 17,200 | $1.02 | $17,544.00 | filing |
| 2025-09-23 | Yu Jeffrey· Chief Medical Officer | Buy | 5,700 | $0.93 | $5,301.00 | filing |
| 2025-09-22 | Yu Jeffrey· Chief Medical Officer | Buy | 400 | $0.95 | $380.00 | filing |
| 2025-09-19 | Yu Jeffrey· Chief Medical Officer | Buy | 1,250 | $0.89 | $1,112.50 | filing |
| 2025-09-18 | Yu Jeffrey· Chief Medical Officer | Buy | 700 | $0.91 | $637.00 | filing |
| 2025-09-05 | Yu Jeffrey· Chief Medical Officer | Buy | 2,100 | $0.86 | $1,806.00 | filing |
| 2025-09-04 | Yu Jeffrey· Chief Medical Officer | Buy | 11,810 | $0.87 | $10,274.70 | filing |
| 2025-09-03 | Yu Jeffrey· Chief Medical Officer | Buy | 11,670 | $0.81 | $9,452.70 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.